Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2139]

Pfizer discontinues phase 3 trial of figitumumab in non small cell lung cancer

Pfizer discontinues phase 3 trial of figitumumab in non small cell lung cancer

Phase 3 Sunitinib for advanced breast cancer fails primary endpoints

Phase 3 Sunitinib for advanced breast cancer fails primary endpoints

Update on phase 3 study of Avastin in men with late stage prostate cancer

Update on phase 3 study of Avastin in men with late stage prostate cancer

Reovirus may be novel approach to prostate cancer treatment

Reovirus may be novel approach to prostate cancer treatment

Prostate cancer treatment choices vary based on type of specialist consulted

Prostate cancer treatment choices vary based on type of specialist consulted

Weekly Review of oncology literature compiled by Giuseppe Curigliano, Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy

Weekly Review of oncology literature compiled by Giuseppe Curigliano, Division of Medical Oncology, Istituto...

Robotic surgery - time to reassess?

Robotic surgery - time to reassess?

Cabazitaxel prolongs survival in men with advanced prostate cancer

Cabazitaxel prolongs survival in men with advanced prostate cancer

Hormone therapy plus radiation improves survival and reduces recurrence in men with intermediate-risk early-stage prostate cancer

Hormone therapy plus radiation improves survival and reduces recurrence in men with intermediate-risk early-stage...

Study validates use of PCA3 urine test to guide prostate biopsy decisions

Study validates use of PCA3 urine test to guide prostate biopsy decisions

More from ecancer